Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE (ombitasvir, paritaprevir and ritonavir) tablets
July 24, 2015 at 14:50 PM EDT
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small ...